Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T Schwannoma cells

Journal of Lipid Research

Volumn 50, Issue 6, 2009, Pages 1203-1208

  Alderson, Nathan L ^a,b   Hama, Hiroko ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cell cycle control; Cyclin dependent kinase inhibitor; Fatty acid hydroxylase; Hydroxy fatty acids; Sphingolipid

Indexed keywords

CERAMIDE; CYCLIC AMP; FATTY ACID; FATTY ACID 2 HYDROXYLASE; HYDROLASE; PROTEIN P21; PROTEIN P27; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; RAT; SCHWANN CELL; UPREGULATION;

ANIMALS; BUCLADESINE; CELL CYCLE; CELL LINE, TUMOR; CERAMIDES; FATTY ACIDS; GENE SILENCING; MIXED FUNCTION OXYGENASES; NEURILEMMOMA; RATS; RNA, SMALL INTERFERING; SPHINGOLIPIDS; UP-REGULATION;

EID: 67650561411     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800666-JLR200     Document Type: Article

References (39)

1. Hakomori, S. 2003. Structure, organization, and function of glycosphingolipids in membrane. Curr. Opin. Hematol. 10: 16-24.
2. Sillence, D. J., and F. M. Platt. 2004. Glycosphingolipids in endocytic membrane transport. Semin. Cell Dev. Biol. 15: 409-416.
3. Futerman, A. H., and Y. A. Hannun. 2004. The complex life of simple sphingolipids. EMBO Rep. 5: 777-782.
4. Norton, W. T., and W. Cammer. 1984. Isolation and characterization of myelin. In Myelin. P. Morell, editor. Plenum, New York, NY. 147-195.
5. Downing, D. T. 1992. Lipid and protein structures in the permeability barrier of mammalian epidermis. J. Lipid Res. 33: 301-313.
6. Breimer, M. E. 1975. Distribution of molecular species of sphingomyelins in different parts of bovine digestive tract. J. Lipid Res. 16: 189-194.
7. Breimer, M. E., K. A. Karlsson, and B. E. Samuelsson. 1975. Presence of phytosphingosine combined with 2-hydroxy fatty acids in sphingomyelins of bovine kidney and intestinal mucosa. Lipids. 10: 17-19.
8. Robinson, B. S., D. W. Johnson, and A. Poulos. 1992. Novel molecular species of sphingomyelin containing 2-hydroxylated polyenoic very-long-chain fatty acids in mammalian testes and spermatozoa. J. Biol. Chem. 267: 1746-1751.
9. Bouhours, J. F., D. Bouhours, and G. C. Hansson. 1993. Developmental changes of glycosphingolipid composition of epithelia of rat digestive tract. Adv. Lipid Res. 26: 353-372.
10. Dahiya, R., M. D. Brown, and T. A. Brasitus. 1986. Distribution of glycosphingolipids ofmonkey small and large intestinal mucosa. Lipids. 21: 107-111.
11. Nilsson, O., and L. Svennerholm. 1982. Characterization and quantitative determination of gangliosides and neutral glycosphingolipids in human liver. J. Lipid Res. 23: 327-334.
12. Riboni, L., D. Acquotti, R. Casellato, R. Ghidoni, G. Montagnolo, A. Benevento, L. Zecca, F. Rubino, and S. Sonnino. 1992. Changes of the human liver GM3 ganglioside molecular species during aging. Eur. J. Biochem. 203: 107-113.
13. Kiguchi, K., K. Takamatsu, J. Tanaka, S. Nozawa, M. Iwamori, and Y. Nagai. 1992. Glycosphingolipids of various human ovarian tumors: a significantly high expression of I3SO3GalCer and lewis antigen in mucinous cystadenocarcinoma. Cancer Res. 52: 416-421.
14. Ladisch, S., C. C. Sweeley, H. Becker, and D. Gage. 1989. Aberrant fatty acyl α-hydroxylation in human neuroblastoma tumor gangliosides. J. Biol. Chem. 264: 12097-12105.
15. Nilsson, O., F. T. Brezicka, J. Holmgren, S. Sorenson, L. Svennerholm, F. Yngvason, and L. Lindholm. 1986. Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1. Cancer Res. 46: 1403-1407.
16. Hakomori, S., E. Nudelman, S. B. Levery, and R. Kannagi. 1984. Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain. J. Biol. Chem. 259: 4672-4680.
17. Yang, H. J., and S. I. Hakomori. 1971. A sphingolipid having a novel type of ceramide and lacto-N-fucopentaose III. J. Biol. Chem. 246: 1192-1200.
18. Ugorski, M., P. Pahlsson, D. Dus, B. Nilsson, and C. Radzikowski. 1989. Glycosphingolipids of human urothelial cell lines with different grades of transformation. Glycoconj. J. 6: 303-318.
19. Kiguchi, K., Y. Iwamori, N. Suzuki, Y. Kobayashi, B. Ishizuka, I. Ishiwata, T. Kita, Y. Kikuchi, and M. Iwamori. 2006. Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance. Cancer Sci. 97: 1321-1326.
20. Alderson, N. L., B. M. Rembiesa, M. D. Walla, A. Bielawska, J. Bielawski, and H. Hama. 2004. The human FA2H gene encodes a fatty acid 2-hydroxylase. J. Biol. Chem. 279: 48562-48568.
21. Eckhardt, M., A. Yaghootfam, S. N. Fewou, I. Zoller, and V. Gieselmann. 2005. A mammalian fatty acid hydroxylase responsible for the formation of alpha-hydroxylated galactosylceramide in myelin. Biochem. J. 388: 245-254.
22. Alderson, N. L., E. N. Maldonado, M. J. Kern, N. R. Bhat, and H. Hama. 2006. FA2H-dependent fatty acid 2-hydroxylation in post-natal mouse brain. J. Lipid Res. 47: 2772-2780.
23. Maldonado, E. N., N. L. Alderson, P. V. Monje, P. M. Wood, and H. Hama. 2008. FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin. J. Lipid Res. 49: 153-161.
24. Uchida, Y., H. Hama, N. L. Alderson, S. Douangpanya, Y. Wang, D. A. Crumrine, P. M. Elias, and W. M. Holleran. 2007. Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-associated increase in 2-OH ceramides during keratinocyte differentiation. J. Biol. Chem. 282: 13211-13219.
25. Bansal, R., and S. E. Pfeiffer. 1987. Regulated galactolipid synthesis and cell surface expression in schwann cell line D6P2T. J. Neurochem. 49: 1902-1911.
26. Winer, J., C. K. Jung, I. Shackel, and P. M. Williams. 1999. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270: 41-49.
27. Alderson, N. L., M. D. Walla, and H. Hama. 2005. A novel method for the measurement of in vitro fatty acid 2-hydroxylase activity by gas chromatography-mass spectrometry. J. Lipid Res. 46: 1569-1575.
28. Hai, M., N. Muja, G. H. DeVries, R. H. Quarles, and P. I. Patel. 2002. Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J. Neurosci. Res. 69: 497-508.
29. Friessen, A. J., W. K. Miskimins, and R. Miskimins. 1997. Cyclin-dependent kinase inhibitor p27kip1 is expressed at high levels in cells that express a myelinating phenotype. J. Neurosci. Res. 50: 373-382.
30. Tikoo, R., G. Zanazzi, D. Shiffman, J. Salzer, and M. V. Chao. 2000. Cell cycle control of schwann cell proliferation: Role of cyclin-dependent kinase-2. J. Neurosci. 20: 4627-4634.
31. Atanasoski, S., D. Boller, L. De Ventura, H. Koegel, M. Boentert, P. Young, S. Werner, and U. Suter. 2006. Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation. Glia. 53: 147-157.
32. Besson, A., S. F. Dowdy, and J. M. Roberts. 2008. CDK inhibitors: cell cycle regulators and beyond. Dev. Cell. 14: 159-169.
33. Chu, I. M., L. Hengst, and J. M. Slingerland. 2008. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer. 8: 253-267.
34. Hannun, Y. A., and L. M. Obeid. 2008. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9: 139-150.
35. Ruvolo, P. P. 2003. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol. Res. 47: 383-392.
36. Schneider, C., G. M. Rath, N. Delorme, H. El Btaouri, W. Hornebeck, and L. Martiny. 2005. Interleukin-1beta (IL-1beta) induces a crosstalk between camp and ceramide signaling pathways in thyroid epithelial cells. Biochimie. 87: 1121-1126.
37. See, V., B. Koch, and J. P. Loeffler. 2001. C2-ceramide and reactive oxygen species inhibit pituitary adenylate cyclase activating poly-peptide (PACAP)-induced cyclic-AMP-dependent signalling pathway. J. Neurochem. 76: 778-788.
38. Mizutani, Y., A. Kihara, H. Chiba, H. Tojo, and Y. Igarashi. 2008. 2-hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length. J. Lipid Res. 49: 2356-2364.
39. Dickson, R. C., G. B. Wells, A. Schmidt, and R. L. Lester. 1990. Isolation of mutant Saccharomyces cerevisiae strains that survive without sphingolipids. Mol. Cell. Biol. 10: 2176-2181.